78 related articles for article (PubMed ID: 2859032)
1. Metabolic effects of various beta-adrenoceptor blocking agents in rats and dogs.
Traunecker W
Arzneimittelforschung; 1985; 35(1A):376-82. PubMed ID: 2859032
[TBL] [Abstract][Full Text] [Related]
2. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
Koebe P; Rost R; Reinke A; Nagel N; Merten U
Arzneimittelforschung; 1985; 35(2):522-9. PubMed ID: 2859861
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical studies of acebutolol-the beta1 specificity of acebutolol (author's transl)].
Hamada Y; Sato I; Ito K; Kuwabara S; Kojima Y
Nihon Yakurigaku Zasshi; 1977 Jul; 73(5):591-6. PubMed ID: 21835
[TBL] [Abstract][Full Text] [Related]
4. [Consequences of the administration of alpha or beta drenolytic agents on the mobilization of plasma free fatty acids as induced by noradrenaline and isoprenaline in the dog].
Berlan M
C R Seances Soc Biol Fil; 1976 Oct; 170(3):672-9. PubMed ID: 10055
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the cardioselectivity of five beta-adrenoceptor blocking drugs.
Pringle TH; Riddell JG; Shanks RG
J Cardiovasc Pharmacol; 1987 Aug; 10(2):228-37. PubMed ID: 2441175
[TBL] [Abstract][Full Text] [Related]
6. Beta-adrenoblocking activity of a new derivative of 2-aminotetraline based on some metabolic responses in cats and rats.
Bogoslovova T; Staneva-Stoytcheva D
Acta Physiol Pharmacol Bulg; 1988; 14(3):39-45. PubMed ID: 2906208
[TBL] [Abstract][Full Text] [Related]
7. Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist.
Irie Y; Igawa T; Hosokawa T; Saitoh Y
Eur J Pharmacol; 1979 Feb; 53(4):351-8. PubMed ID: 33812
[TBL] [Abstract][Full Text] [Related]
8. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
Pringle TH; McNeill AJ; Riddell JG; Shanks RG
Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
[TBL] [Abstract][Full Text] [Related]
9. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
Maruyama Y; Awaji T; Inoue M; Takeo S
Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
[TBL] [Abstract][Full Text] [Related]
10. Effects of 1-(4-nitrophenyl)-2-isopropylaminoethanol (INPEA) and propranolol and their dextro-isomers on hemodynamic and metabolic responses to isoproterenol in dogs.
Nishimura T; Kita S; Abiko Y
J Pharmacol Exp Ther; 1983 Aug; 226(2):595-602. PubMed ID: 6688273
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
12. [Bepridil, a functional antagonist of beta1-adrenergic stimulation. Dissociated effects on cardiostimulation and lipolysis. (author's transl)].
Constantin M; Beaughard M; Piris P; Labrid C
J Pharmacol; 1981; 12(3):239-54. PubMed ID: 6116833
[TBL] [Abstract][Full Text] [Related]
13. The effects of beta-adrenoceptor blocking drugs on non-esterified fatty acid release from adipocytes.
Harms HH
J Pharmacol; 1983; 14 Suppl 2():209-15. PubMed ID: 6138469
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological properties of an extremely selective beta 1-adrenoceptor antagonist, 2-[4-[3-(tert-Butylamino)-2-hydroxypropoxy] phenyl]-3-methyl-6-methoxy-4(3H)-quinazolinone [+/-)HX-CH 44 BS).
Daemmgen JW; Engelhardt G; Pelzer H
Arzneimittelforschung; 1985; 35(1A):383-90. PubMed ID: 2859033
[TBL] [Abstract][Full Text] [Related]
15. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
Smith HJ; Halliday SE; Earl DC; Stribling D
J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
[TBL] [Abstract][Full Text] [Related]
16. [Effects of adrenergic blockade on adipose tissue lipolysis provoked in cats and humans by intravenous perfusion of isoprenaline].
Ashford A
Nouv Presse Med; 1975 Dec; 4(46 Suppl):3265-7. PubMed ID: 3767
[TBL] [Abstract][Full Text] [Related]
17. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
Lindner E
Arzneimittelforschung; 1984; 34(3):270-6. PubMed ID: 6145430
[TBL] [Abstract][Full Text] [Related]
18. Study of the metabolic effects of bunitrolol (Koe 1366) in angina induced by catecholamine infusion.
Cuccurullo F; Masi M; Mezzetti A; Rosini R; Luciani G; Tomassetti V; Abate G; Lenzi S
Arzneimittelforschung; 1979; 29(1):138-41. PubMed ID: 36102
[TBL] [Abstract][Full Text] [Related]
19. Metabolic consequences of beta-adrenergic receptor blockade for the acutely ischemic dog myocardium.
Westera G; van der Wall EE; van Eenige MJ; Scholtalbers S; den Hollander W; Visser FC; Roos JP
Nuklearmedizin; 1984 Feb; 23(1):35-40. PubMed ID: 6145147
[TBL] [Abstract][Full Text] [Related]
20. [Influence of alpha or beta adrenergic antagonists on catecholamine dependent metabolic effects in pigs].
Brenner KV; Gürtler H
Acta Biol Med Ger; 1981; 40(12):1759-66. PubMed ID: 6125073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
